News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Asan Medical Center and Chemizon Inc. Forge a Broad Oncology Partnership in Drug Discovery, Drug Development and Translational Medicine


1/25/2010 11:59:56 AM

SEOUL, South Korea--(BUSINESS WIRE)--Asan Medical Center and Chemizon, the drug discovery division of Optomagic, Co. Ltd. (KOSDAQ: OPTOMAGIC [A010170]), announced today that they have entered into a multi-year research collaboration to discover and develop novel, small molecule oncology therapeutics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES